Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Fukuoka University has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 distinct examiner and 1 distinct art unit, so the available prosecution activity is concentrated in one examination setting.
MOSS, NATALIE M is the busiest examiner, with 1 pending matter. Counsel can focus the response on the specific issues presented by that examiner without managing parallel examiner assignments.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOSS, NATALIE M | 1 | 30.7% | +17.2% |
| VANHORN, ABIGAIL LOUISE | 1 | 46.8% | +22.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17754196 | OLIGONUCLEOTIDE, AND TARGET RNA SITE-SPECIFIC EDITING METHOD | VANHORN, ABIGAIL LOUISE | 33d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18277278 | CELL SHEET SUPPORT, CELL SHEET LAMINATE AND METHOD FOR PRODUCING SAME | MOSS, NATALIE M | 3d overdue |
| 17754196 | OLIGONUCLEOTIDE, AND TARGET RNA SITE-SPECIFIC EDITING METHOD | VANHORN, ABIGAIL LOUISE | 33d |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18277278 | CELL SHEET SUPPORT, CELL SHEET LAMINATE AND METHOD FOR PRODUCING SAME | MOSS, NATALIE M | 1653 | §103 | Final Rejection | 3d overdue | Pending | Aug 15, 2023 |
| 17754196 | OLIGONUCLEOTIDE, AND TARGET RNA SITE-SPECIFIC EDITING METHOD | VANHORN, ABIGAIL LOUISE | 1636 | §102§103Other | Non-Final OA | 33d | Pending | Mar 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFukuoka University has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Natalie M Moss has the most, with 1 of Fukuoka University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
